St Georges Vascular Institute, 4th Floor, St James' Wing, St Georges Hospital NHS Trust, London, UK.
St Georges Vascular Institute, 4th Floor, St James' Wing, St Georges Hospital NHS Trust, London, UK.
Eur J Vasc Endovasc Surg. 2014 Jun;47(6):621-39. doi: 10.1016/j.ejvs.2014.02.009. Epub 2014 Mar 15.
Endoscopic vein harvesting (EVH) for arterial bypass surgery may be associated with lower wound complication rates than open vein harvesting (OVH), but other long-term outcomes remain controversial, and there are concerns that graft patency may be poorer after EVH compared with OVH. We conducted a systematic review of all available evidence for EVH in lower extremity arterial bypass (LEAB).
A literature search of Medline, Embase, Ovid and Cochrane databases between 1996 and 2013 was performed using the terms "endoscopic vein harvesting", "minimally invasive vein harvest", "peripheral bypass surgery", and "lower extremity bypass surgery", and detailed in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Primary outcomes were graft patency and overall wound complication rates. Secondary outcomes were wound infection, length of hospital stay, and cost-effectiveness. Summary estimates were calculated by random effects meta-analysis if sufficient data were available.
We identified 18 cohort studies and case series, with considerable clinical heterogeneity, including 2,343 patients. Meta-analysis of six studies revealed a significantly reduced rate of primary patency after EVH (hazard ratio 1.29, 95% confidence interval [CI] 1.03-1.63), with no significant difference between EVH and OVH with respect to wound infection in 12 studies (odds ratio 0.81, 95% CI 0.61-1.08). There was a lack of strong evidence to support the secondary outcomes of EVH.
EVH reduces primary patency rates after LEAB, but does not demonstrate an advantage with respect to postoperative wound complications. However, the available data are heterogeneous, and uncertainty is introduced by both evolution in technology and increasing technical experience. EVH should be used with caution and in the context of formal research.
与开放式静脉采集术(OVH)相比,内镜下静脉采集术(EVH)用于动脉旁路手术可能与较低的伤口并发症发生率相关,但其他长期结果仍存在争议,并且有人担心与 OVH 相比,EVH 后移植物通畅率可能较差。我们对所有可用于下肢动脉旁路术(LEAB)的 EVH 证据进行了系统评价。
我们使用“内镜下静脉采集术”、“微创静脉采集”、“外周旁路手术”和“下肢旁路手术”等术语,对 1996 年至 2013 年期间 Medline、Embase、Ovid 和 Cochrane 数据库进行了文献检索,并按照系统评价和荟萃分析的首选报告项目进行了详细说明。主要结果是移植物通畅率和总伤口并发症发生率。次要结果是伤口感染、住院时间和成本效益。如果有足够的数据,将通过随机效应荟萃分析计算汇总估计值。
我们确定了 18 项队列研究和病例系列研究,包括 2343 例患者,具有很大的临床异质性。六项研究的荟萃分析显示,EVH 后原发性通畅率显著降低(风险比 1.29,95%置信区间 [CI] 1.03-1.63),12 项研究中 EVH 与 OVH 之间在伤口感染方面无显著差异(比值比 0.81,95% CI 0.61-1.08)。没有强有力的证据支持 EVH 的次要结果。
EVH 降低了 LEAB 后原发性通畅率,但在术后伤口并发症方面没有优势。然而,现有数据存在异质性,技术的发展和技术经验的增加都会带来不确定性。EVH 应谨慎使用,并在正式研究的背景下使用。